Proteon logo     Print Page | Close Window

2016 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
12/13/16Proteon Therapeutics Announces Top-Line Data from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with CKDPrinter Friendly Version
11/10/16Proteon Therapeutics Announces First Patient Dosed in Phase 1 Study Evaluating Vonapanitase for the Treatment of Peripheral Artery Disease Below the KneePrinter Friendly Version
11/09/16Proteon Therapeutics to Participate in Two Upcoming Investor ConferencesPrinter Friendly Version
11/07/16Proteon Therapeutics Announces Third Quarter 2016 Financial ResultsPrinter Friendly Version
10/25/16Proteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) ConferencePrinter Friendly Version
10/20/16Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of DirectorsPrinter Friendly Version
09/01/16Proteon Therapeutics to Present at Two Upcoming Investor ConferencesPrinter Friendly Version
08/08/16Proteon Therapeutics Announces Second Quarter 2016 Financial ResultsPrinter Friendly Version
06/15/16Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22ndPrinter Friendly Version
05/09/16Proteon Therapeutics Announces First Quarter 2016 Financial ResultsPrinter Friendly Version
04/28/16Proteon Therapeutics Announces Survey Findings Demonstrating Impact of Vascular Access Failure on Hemodialysis PatientsPrinter Friendly Version
04/13/16Proteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery DiseasePrinter Friendly Version
03/14/16Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial ResultsPrinter Friendly Version
03/02/16Proteon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference on March 8thPrinter Friendly Version
02/02/16Proteon Therapeutics to Present at the 2016 BIO CEO & Investor Conference February 8thPrinter Friendly Version